In 2020 we published 19 protocols, 6 reviews, and 9 review updates.
Protocols
- Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
- Prophylactic use of inotropic agents for the prevention of low cardiac output syndrome and mortality in adults undergoing cardiac surgery
- Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation
- The effectiveness of the modified Valsalva Manoeuvre for reversion of supraventricular tachycardia
- Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis
- Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
- Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric patients undergoing surgery for congenital heart disease: a network meta-analysis
- Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis'
- Different rate-controlling agents for the management of atrial fibrillation with rapid ventricular rate in the emergency department: a network meta-analysis
- Coronary artery bypass surgery versus medical therapy alone for ischaemic heart disease
- Transvenous versus subcutaneous implantable cardiac defibrillators for people at risk of sudden cardiac death
- High-intensity interval training for reducing cardiometabolic syndrome in healthy but sedentary populations
- Ultrafiltration for acute heart failure
- Effects of interventions targeting the systemic inflammatory response to cardiac surgery on clinical outcomes in adults
- Ultrasound guidance for arterial (other than femoral) catheterisation in adults
- Prothrombin complex concentrate in cardiac surgery for the treatment of non-surgical bleeding
- Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease
- LCZ696 (sacubitril/valsartan) for patients with heart failure
Reviews
- Advance care planning for adults with heart failure
- Mechanical assist devices for acute cardiogenic shock
- mHealth education interventions in heart failure
- Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass
- Physical activity interventions for people with congenital heart disease
- Ivabradine as adjuvant treatment for chronic heart failure
Updates
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- A comparison of different antibiotic regimens for the treatment of infective endocarditis
- Reduction in saturated fat intake for cardiovascular disease
- Interventions for increasing fruit and vegetable consumption in children aged five years and under
- Effects of total fat intake on body fatness in adults
- Intravenous immunoglobulin for presumed viral myocarditis in children and adults
- PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
- Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome
- Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection)